Healthcare-associated infections (HAIs) are a serious global concern1.
By collaborating with partners, ParaPharm Development Ltd is able to bring to market cost-effective antibiotics to tackle the most serious multi-drug resistant bacteria, whilst striving to protect the effectiveness of the antibiotics currently in use.
Reference: 1. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. World Health Organization. 2011